Article
Genetically-proxied anti-diabetic drug target perturbation and risk of cancer: a Mendelian randomization analysis
2022-10-26
Abstract excerpt
<h4>Aims/hypothesis</h4> Epidemiological studies have generated conflicting findings on the relationship between anti-diabetic medication use and cancer risk. Naturally occurring variation in genes encoding anti-diabetic drug targets can be used to investigate the effect of their pharmacological perturbation on cancer risk. <h4>Methods</h4> We developed genetic instruments for three anti-diabetic drug targets (per...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ba6bd3d9-104a-5ff4-9775-ec7fa5116481
- DOI
- 10.1101/2022.10.24.22281370
